Thymalin
- For in vitro testing and laboratory use only.
- Not for human or animal consumption.
- Bodily introduction is illegal.
- Handle only by licensed professionals.
- Not a drug, food, or cosmetic.
- Educational use only.
The Soviet Ministry of Health approved Thymalin as an immunomodulator in 1982. It's been continuously produced and used clinically in Russia for more than four decades — for chemotherapy recovery, post-surgical immune restoration, radiation exposure, age-related immune decline, and, more recently, severe COVID-19 in elderly patients. 40+ years of clinical use, thousands of patients, peer-reviewed Russian research publications — and meanwhile in the West, most researchers have never heard of it. Thymalin is one of those compounds where the Russian and Western research worlds have barely overlapped.
What Is Thymalin?
Thymalin is a polypeptide complex isolated from the thymus glands of young calves — not a single synthesized peptide. The product is a mild acid extract containing a mixture of peptides with molecular weights up to 10 kDa, including the bioactive short peptides KE (Lys-Glu, dipeptide), EW (Glu-Trp, also marketed separately as Thymogen), and EDP (Glu-Asp-Pro, tripeptide). It's classified as a cytomedin — a class of short peptide bioregulators developed at the St. Petersburg Institute of Bioregulation and Gerontology by Vladimir Khavinson's group.
That mixture-vs-single-peptide distinction matters. Most research peptides on this site are single defined sequences. Thymalin is a natural extract standardized for bioactivity but containing multiple active components. The closest analogy in Western pharmacology is something like silymarin (the milk thistle extract) — a defined preparation with multiple bioactive constituents acting together rather than a single isolated molecule. The distinction has implications for how the compound is studied, manufactured, and verified.
The Khavinson Bioregulator Concept
Thymalin emerged from a Russian research tradition that doesn't have a clean Western equivalent: peptide bioregulators. The core hypothesis Vladimir Khavinson and his collaborators have published on for over four decades is that short peptides — particularly di- and tripeptides — can directly bind double-stranded DNA and histone proteins, regulating gene expression in tissue-specific patterns. The idea that small peptides can act as transcription regulators isn't widely accepted in mainstream Western molecular biology. The Russian research base supporting it is substantial.
The 2021 COVID-19 research from the Khavinson group is illustrative. In severe COVID-19 in elderly patients (n=36), Thymalin added to standard therapy produced more rapid clinical improvement, faster lymphopenia recovery, and accelerated normalization of inflammatory markers compared to standard therapy alone. The proposed mechanism: KE peptide stimulates cellular immunity through macrophage and T-cell activation; EW peptide reduces angiotensin-induced vasoconstriction and preserves vascular endothelial function partly by inhibiting ACE2 (the SARS-CoV-2 receptor); EDP peptide modulates additional immunoregulatory pathways. The 6-year follow-up study by Khavinson and Morozov (2003, Neuro Endocrinology Letters) reported significant mortality reduction in elderly subjects treated with Thymalin and Epitalon — the longest human clinical trial on a peptide bioregulator.
What Serious Buyers Should Know
Here's the uncomfortable truth: most Thymalin research has been done by a single research lineage. Khavinson and colleagues at the St. Petersburg Institute have driven nearly all of the foundational work over four decades. Independent Western replication is genuinely limited. The compound has nearly fifty years of clinical and research history, but a meaningful fraction of it was published in Russian-language journals that aren't widely accessible in English. Thymalin's evidence base is uneven in source diversity in ways that compounds with broader international research adoption aren't.
The bioregulator concept itself remains scientifically contested. Whether short peptides really do bind DNA and regulate gene expression in the specific tissue-targeted ways Khavinson's group has proposed isn't settled in mainstream molecular biology. The 40-year Russian clinical experience strongly suggests the compound does something immunomodulatory. The exact molecular mechanism is more controversial than the published literature sometimes implies.
Regulatory note: Thymalin is a medicinal drug registered with the Russian Ministry of Health (registration number LS-000267, dated February 26, 2010), continuously approved for medical use since 1982 and currently manufactured by Samson-Med LLC in St. Petersburg. In the United States, Thymalin is not on the FDA's 503A bulks list, not FDA-approved for human use, and not part of the recent Category 2 reclassification activity affecting BPC-157, Epitalon, DSIP, and others. As a complex polypeptide extract rather than a synthesized peptide, it occupies a different regulatory category. Sales as a research compound continue legally for laboratory use. WADA's Prohibited List does not specifically name Thymalin as of 2025.
Why Generic Peptides for Thymalin?
Here's a sourcing problem that's specific to Thymalin: it's a natural extract, not a synthetic peptide — meaning the standardization, purity verification, and bioactivity assays needed to confirm consistent quality are fundamentally different from what works for synthetic single-peptide compounds. The Russian Pharmacopoeia standard (Samson-Med produces the Russian medicinal version under that standard) involves specific bioactivity testing for the polypeptide mixture. Cheap suppliers in the research market routinely deliver Thymalin without that level of standardization — the molecular weight distribution may be wrong, the active dipeptide and tripeptide components may be present at inconsistent ratios, and the bioactivity that defines clinical-quality Thymalin may be substantially reduced. Without analytical verification of the full peptide composition, you may be buying calf thymus extract that's structurally similar to Thymalin but pharmacologically inconsistent batch-to-batch.
Generic Peptides supplies research-grade Thymalin for sale at 99% purity, manufactured in the USA. Domestic processing with documented peptide composition — the part that determines whether your Thymalin behaves like the standardized Russian medicinal preparation that 40+ years of clinical research describes.
Order Thymalin for sale in the USA — 99% purity, documented polypeptide composition, manufactured domestically.
Thymalin FAQ
Is it legal to buy Thymalin in the US for research?
Yes — Thymalin is legally available as a research compound in the United States. It's not on the FDA's 503A bulks list and wasn't part of the recent Category 2 reclassification activity. It's not FDA-approved for human use, though it's been a registered medicinal drug in Russia since 1982. As a polypeptide extract, it occupies a different regulatory category from most synthesized research peptides.
Is Thymalin a single peptide or a mixture?
A mixture. Thymalin is a polypeptide complex extracted from calf thymus, containing multiple bioactive peptides up to 10 kDa molecular weight. The most-studied active components are the dipeptide KE (Lys-Glu), the dipeptide EW (Glu-Trp, also marketed as Thymogen), and the tripeptide EDP (Glu-Asp-Pro). Different from synthesized single-sequence research peptides.
What's the difference between Thymalin and Thymosin Alpha-1?
Different compounds entirely. Thymosin Alpha-1 is a single defined 28-amino-acid peptide isolated and characterized in the West, with separate research base and FDA-approved indications in some countries (Zadaxin). Thymalin is a Russian-developed thymic polypeptide complex (mixture) with KE, EW, and EDP as principal active components. Different molecules, different research traditions, different regulatory pathways.
Is the bioregulator hypothesis real science?
The bioregulator concept — that short peptides directly regulate gene expression by binding DNA and histones — is a Russian research framework that hasn't been widely adopted in mainstream Western molecular biology. The clinical observations supporting Thymalin's effects are extensive (4+ decades, thousands of patients). The proposed molecular mechanism remains scientifically contested. The compound clearly does something immunomodulatory; the exact mechanism is less settled than some sources suggest.
I've seen Thymalin sold cheap online — same product?
Probably not at the same standardization. As a polypeptide extract rather than a synthesized peptide, Thymalin's quality depends on extraction methodology, peptide composition standardization, and bioactivity verification. Cheap suppliers routinely deliver calf thymus extracts that may share the broad structural category but lack the consistent peptide composition of the Russian-standardized medicinal preparation.
Sources
Khavinson VK, Kuznik BI, Shapovalov YA et al. — "Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients." Advances in Gerontology, 2021. Documents the clinical trial in severe COVID-19 patients. https://link.springer.com/article/10.1134/S2079057021040068
Linkova NS, Drobintseva AO, Orlova OA et al. — "The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity." PMC, 2021. Documents the molecular mechanisms of KE, EW, and EDP active components. https://pmc.ncbi.nlm.nih.gov/articles/PMC8365293/
Khavinson VK, Morozov VG — "Peptides of pineal gland and thymus prolong human life." Neuro Endocrinology Letters, 2003. Long-term human study documenting significant mortality reduction with Thymalin and Epitalon over 6-year follow-up — the longest human clinical trial on a peptide bioregulator. https://pubmed.ncbi.nlm.nih.gov/14523363/
Morozov VG, Khavinson VK — "Natural and synthetic thymic peptides as therapeutics for immune dysfunction." International Journal of Immunopharmacology, 1997. Foundational paper on the Thymalin extract and its synthetic dipeptide derivatives. https://www.sciencedirect.com/science/article/abs/pii/S0192056197000581
A 40-year Russian research tradition. A polypeptide mixture, not a single peptide. Standardization is the entire question.
Thymalin Storage Guide: How to Keep Your Research Peptide Stable and Effective
Thymalin ships as a white lyophilized powder in a sealed glass vial, freeze-dried to preserve this thymic polypeptide complex and extend its shelf life. With a few simple habits — cold, dark, dry — the sealed vial stays in perfect condition for its full shelf life. Here's exactly how to store it.
Lyophilized Powder (Unreconstituted)
| Parameter | Details | Notes |
|---|---|---|
| Storage Temperature | Freezer at −20°C (−4°F) for long-term storage up to 24 months. Refrigeration at 2–8°C (36–46°F) is fine for short-term use up to ~3 months. | Original sealed vial in the freezer is the safest default. |
| Light Sensitivity | Yes — thymalin's tryptophan-containing component (Glu-Trp) is particularly prone to photodegradation. | Always keep in the original box or an opaque, amber container. |
| Freezing | Allowed and recommended. −20°C is standard for long-term storage; −80°C extends stability further if available. | Freeze from the start if you won't use it within 3 months. |
| Oxidation Sensitivity | Thymalin is a peptide mixture that includes tryptophan-containing fragments, which are prone to oxidation if the vial seal is broken or the powder is exposed to air. | Keep the aluminum crimp cap intact until ready to reconstitute. |
| Signs of Degradation | Healthy powder is white to off-white and loose or cake-like. Watch for yellowing, browning, clumping, visible moisture, or a sticky texture. | Any color change, clumping, or moisture = discard the vial. |
| Common Mistakes | Leaving the vial at room temperature after delivery, storing in a humid kitchen or bathroom, or opening a cold vial and letting condensation form inside. | Put it in the freezer on arrival, and let sealed vials warm to room temperature before opening. |
Shipping & Product Authenticity
Every order is processed quickly and shipped with full tracking. All products come directly from the official Generic Peptides supply chain — in original manufacturer packaging, carefully handled from warehouse to your door.
Shipping Times
| Destination | Delivery Time | Notes |
|---|---|---|
| USA Domestic | 2–5 business days | Faster when local warehouse stock is selected at checkout |
| International | 10–15 business days | Tracking included; update frequency may vary by destination country |
| Order Processing | 24–48 business hours | Processing begins after payment confirmation |
| Tracking | Provided on all orders | Tracking number sent after dispatch; multiple warehouses may result in separate shipments |
Direct Supply & Secure Delivery
This product is supplied through the official Generic Peptides distribution chain and shipped in original manufacturer packaging. Orders are packed securely to protect the contents during transit and to respect customer privacy as a standard practice.
Outer packaging is neutral and does not display product details on the exterior — a common approach to protect shipments from damage, tampering, and unnecessary exposure during delivery.
What to Expect
- Orders are processed after payment confirmation
- USA domestic shipping is typically faster when local stock is selected
- International orders include tracking, though update frequency may vary by destination
- Multiple warehouses may result in separate shipments when applicable
Authenticity & Verified Supply
Every order includes full authenticity assurance: official Generic Peptides presentation, batch-linked lab documentation, and sealed original packaging — giving customers confidence in every purchase.
| Authenticity Feature | Details |
|---|---|
| Packaging | Original manufacturer packaging — sealed and unaltered |
| Lab Documentation | Batch-linked certificate of analysis available on request |
| Supply Chain | Sourced exclusively through official Generic Peptides distribution |
Shipping & Returns
Based on 1 reviews
5.0
Good supplier. Shipping was around a week, packaged well, communication was professional. Only nitpick — I wish they'd send tracking automatically instead of having to request it. Otherwise no issues.
The proposed mechanism involves the bioactive short peptides in the extract — particularly KE (Lys-Glu), EW (Glu-Trp), and EDP (Glu-Asp-Pro). These peptides reportedly bind double-stranded DNA and histone proteins, regulating gene expression involved in cellular immunity, T-cell maturation, cytokine balance, and stem cell differentiation. The downstream effects include normalized CD4/CD8 T-cell ratios, modulated pro-/anti-inflammatory cytokine balance, and enhanced hematopoietic stem cell differentiation.
Thymogen is the synthetic dipeptide EW (Glu-Trp, also written as l-Glu-l-Trp) isolated from Thymalin and developed as a separate single-peptide pharmaceutical product. Thymalin is the broader polypeptide complex extracted from calf thymus, containing EW alongside other active peptides like KE and EDP. Thymogen represents one isolated active component; Thymalin contains multiple components acting together.
The cytomedin classification refers to a group of short peptide bioregulators developed by Vladimir Khavinson's research group at the St. Petersburg Institute of Bioregulation and Gerontology. The concept describes short peptides that act as tissue-specific gene regulators — Thymalin (thymus), Epithalamin/Epitalon (pineal gland), Cortexin (cerebral cortex), and others form the original cytomedin series. The framework is uniquely Russian and not widely adopted in Western molecular biology.
As a natural extract rather than a synthesized peptide, Thymalin's quality depends on calf thymus tissue source, extraction methodology, peptide composition standardization, and bioactivity verification. The Russian Pharmacopoeia standard (Samson-Med produces the medicinal version under that standard) involves specific bioactivity testing. Cheap research-market suppliers often deliver calf thymus extracts without comparable standardization, producing inconsistent peptide ratios and bioactivity.
Thymalin was developed in the late 1970s at the Military Medical Academy in Leningrad (St. Petersburg) and subsequently at the Institute of Bioregulation and Gerontology by Vladimir Khavinson and Vyacheslav Morozov. The Soviet Ministry of Health approved it as a medicinal drug in 1982. Forty-plus years of continuous clinical use and research follow.
Thymalin is not specifically named on the WADA Prohibited List as of 2025. As an immunomodulatory polypeptide extract without anabolic or hormonal effects, it doesn't fit standard performance-enhancing categories. Athletes subject to drug testing should consult their governing body's specific rules — anti-doping rules can include unspecified substances under broad categories.
Tactivin (a related Russian thymic preparation, sometimes confused with Thymalin), Thymactide (alternate transliteration), and the Russian medical name тималин. In some contexts also called calf thymus extract or thymic peptide complex. The polypeptide mixture is the same regardless of label naming convention.
Immunomodulation and immune restoration research lead by volume — chemotherapy recovery, post-surgical immune support, infectious disease (most recently severe COVID-19), and age-related immune decline. There's also active work in gerontology (the "geroprotective" applications), hematopoietic stem cell research, and thymus involution research. Russian gerontology research has continued investigating Thymalin in combination with other Khavinson-developed bioregulator peptides.
Thymalin is a complex polypeptide extract; Thymopentin is a synthesized 5-amino-acid peptide (RKDVY) corresponding to the active site of Thymopoietin. Different compounds with different research traditions — Thymopentin emerged from Western pharmaceutical development and reached limited clinical use; Thymalin emerged from Russian research and remains predominantly used in Russia. Both target thymic immune regulation but through different molecular tools.
Most modern immunomodulator research peptides are single defined sequences with characterized receptor targets and mechanisms. Thymalin is a natural polypeptide mixture containing multiple bioactive components acting on what Russian research describes as tissue-specific gene regulation. That extract-based pharmacology is mechanistically distinct from single-peptide approaches, and it's part of why Thymalin has remained primarily a Russian medical and research compound rather than entering mainstream Western pharmaceutical development.
Researchers investigating peptide bioregulators, thymic immune function, and longevity-focused aging biology consistently examine Thymalin alongside compounds that target overlapping or complementary aspects of immune senescence and anti-aging research. Epitalon is the defining pairing — the Khavinson group's foundational 6-year mortality study used both compounds together, with Thymalin representing the thymus arm and Epitalon representing the pineal gland arm of the same peptide bioregulator research tradition; the two are almost always examined together in longevity research designs that follow the Russian bioregulator protocol. Thymosin Alpha-1 targets thymic immune function through a different mechanism — single defined 28-amino-acid peptide with TLR2/TLR9 activation rather than Thymalin's polypeptide complex approach, making it a useful Western pharmacological reference for researchers comparing Russian bioregulator preparations against internationally approved thymic peptides. DSIP shares the neuroendocrine aging research context — both Thymalin and DSIP appear in the same Khavinson research tradition studying peptide bioregulators across multiple organ systems, and researchers examining comprehensive bioregulator protocols sometimes examine both simultaneously. NAD+ addresses cellular aging through energy metabolism and sirtuin activation — a complementary mechanistic approach to Thymalin's immune-focused bioregulator effects for researchers studying aging biology from multiple angles simultaneously. BPC-157 occasionally appears in the same immune modulation and tissue repair context given both compounds' documented effects on inflammatory pathways and immune cell function.
